Consistent with data on the mRNA expression of TRIP13, its immunophenotypic expression was independent of tumor stage (Supplementary Fig. 2B) and patient race (Supplementary Fig. 2C), gender (Supplementary Fig. 2D), and age (Supplementary Fig. 2E). Here, TRIP13 is linked to neoplasm.